Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc.

He W, Li Y, Chen X, Lu L, Tang B, Wang Z, Pan Y, Cai S, He Y, Ke Z.

J Gastroenterol Hepatol. 2014;29(7):1427-34. doi: 10.1111/jgh.12558.

PMID:
24612089
2.

Downregulation of microRNA-155 accelerates cell growth and invasion by targeting c-myc in human gastric carcinoma cells.

Sun S, Sun P, Wang C, Sun T.

Oncol Rep. 2014 Sep;32(3):951-6. doi: 10.3892/or.2014.3288. Epub 2014 Jun 24.

PMID:
24969405
3.

miR-429 modulates the expression of c-myc in human gastric carcinoma cells.

Sun T, Wang C, Xing J, Wu D.

Eur J Cancer. 2011 Nov;47(17):2552-9. doi: 10.1016/j.ejca.2011.05.021. Epub 2011 Jun 16.

PMID:
21684154
4.

Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer.

Liu Y, Zhang X, Zhang Y, Hu Z, Yang D, Wang C, Guo M, Cai Q.

Cancer Lett. 2015 Dec 1;369(1):58-66. doi: 10.1016/j.canlet.2015.06.028. Epub 2015 Aug 11.

PMID:
26276722
5.

MicroRNA-182 promotes tumor cell growth by targeting transcription elongation factor A-like 7 in endometrial carcinoma.

Guo Y, Liao Y, Jia C, Ren J, Wang J, Li T.

Cell Physiol Biochem. 2013;32(3):581-90. doi: 10.1159/000354462. Epub 2013 Sep 6.

6.

The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E.

Li W, Jin X, Deng X, Zhang G, Zhang B, Ma L.

Biochem Biophys Res Commun. 2014 Jun 27;449(2):235-40. doi: 10.1016/j.bbrc.2014.05.011. Epub 2014 May 15.

PMID:
24845562
7.

Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.

Yang X, Cai H, Liang Y, Chen L, Wang X, Si R, Qu K, Jiang Z, Ma B, Miao C, Li J, Wang B, Gao P.

Oncol Rep. 2015 Apr;33(4):1723-30. doi: 10.3892/or.2015.3757. Epub 2015 Jan 28.

PMID:
25633261
8.

Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability.

Yang F, Xue X, Zheng L, Bi J, Zhou Y, Zhi K, Gu Y, Fang G.

FEBS J. 2014 Feb;281(3):802-13. doi: 10.1111/febs.12625. Epub 2014 Jan 15.

9.

MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor.

Zhao X, Dou W, He L, Liang S, Tie J, Liu C, Li T, Lu Y, Mo P, Shi Y, Wu K, Nie Y, Fan D.

Oncogene. 2013 Mar 14;32(11):1363-72. doi: 10.1038/onc.2012.156. Epub 2012 May 21.

PMID:
22614005
10.

miRNA-145 targets v-ets erythroblastosis virus E26 oncogene homolog 1 to suppress the invasion, metastasis, and angiogenesis of gastric cancer cells.

Zheng L, Pu J, Qi T, Qi M, Li D, Xiang X, Huang K, Tong Q.

Mol Cancer Res. 2013 Feb;11(2):182-93. doi: 10.1158/1541-7786.MCR-12-0534. Epub 2012 Dec 11.

11.

MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients.

Chen YJ, Wu H, Zhu JM, Li XD, Luo SW, Dong L, Liu TT, Shen XZ.

J Gastroenterol Hepatol. 2016 Jan;31(1):155-63. doi: 10.1111/jgh.13041.

PMID:
26173586
12.

Downregulation of tumor suppressor MBP-1 by microRNA-363 in gastric carcinogenesis.

Hsu KW, Wang AM, Ping YH, Huang KH, Huang TT, Lee HC, Lo SS, Chi CW, Yeh TS.

Carcinogenesis. 2014 Jan;35(1):208-17. doi: 10.1093/carcin/bgt285. Epub 2013 Aug 23.

PMID:
23975832
13.

Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.

Xiong J, Du Q, Liang Z.

Oncogene. 2010 Sep 2;29(35):4980-8. doi: 10.1038/onc.2010.241. Epub 2010 Jun 21.

PMID:
20562918
14.

MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.

Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y, Yao H, Liu X, Ke Y, Si J, Zhou T.

Cell Res. 2010 Jul;20(7):784-93. doi: 10.1038/cr.2010.79. Epub 2010 Jun 15.

PMID:
20548334
15.

TSPAN1 functions as an oncogene in gastric cancer and is downregulated by miR-573.

Lu Z, Luo T, Nie M, Pang T, Zhang X, Shen X, Ma L, Bi J, Wei G, Fang G, Xue X.

FEBS Lett. 2015 Jul 8;589(15):1988-94. doi: 10.1016/j.febslet.2015.05.044. Epub 2015 Jun 6.

16.

A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.

Kong LM, Liao CG, Zhang Y, Xu J, Li Y, Huang W, Zhang Y, Bian H, Chen ZN.

Cancer Res. 2014 Jul 15;74(14):3764-78. doi: 10.1158/0008-5472.CAN-13-3555. Epub 2014 Jun 6.

17.

Down-Regulation of MiR-1294 is Related to Dismal Prognosis of Patients with Esophageal Squamous Cell Carcinoma through Elevating C-MYC Expression.

Liu K, Li L, Rusidanmu A, Wang Y, Lv X.

Cell Physiol Biochem. 2015;36(1):100-10. doi: 10.1159/000374056. Epub 2015 Apr 27. Erratum in: Cell Physiol Biochem. 2015;37(6):2508.

18.

Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2.

Wang B, Hsu SH, Wang X, Kutay H, Bid HK, Yu J, Ganju RK, Jacob ST, Yuneva M, Ghoshal K.

Hepatology. 2014 Feb;59(2):555-66. doi: 10.1002/hep.26712. Epub 2013 Dec 20.

19.

MicroRNA-449a inhibits proliferation and induces apoptosis by directly repressing E2F3 in gastric cancer.

Li X, Li H, Zhang R, Liu J, Liu J.

Cell Physiol Biochem. 2015;35(5):2033-42. doi: 10.1159/000374010. Epub 2015 Mar 30.

20.

MicroRNA-339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1.

Shen B, Zhang Y, Yu S, Yuan Y, Zhong Y, Lu J, Feng J.

FEBS Lett. 2015 Oct 7;589(20 Pt B):3205-11. doi: 10.1016/j.febslet.2015.09.009. Epub 2015 Sep 29.

Supplemental Content

Support Center